The genetic basis of addictive disorders.
- Authors
- Ducci, Francesca; Goldman, David
- Year
- 2012
- Journal
- The Psychiatric clinics of North America
- PMID
- 22640768
- DOI
- 10.1016/j.psc.2012.03.010
- PMCID
- PMC3506170
Addictions are common, chronic, and relapsing diseases that develop through a multistep process. The impact of addictions on morbidity and mortality is high worldwide. Twin studies have shown that the heritability of addictions ranges from 0.39 (hallucinogens) to 0.72 (cocaine). Twin studies indicate that genes influence each stage from initiation to addiction, although the genetic determinants may differ. Addictions are by definition the result of gene Γ environment interaction. These disorders, which are in part volitional, in part inborn, and in part determined by environmental experience, pose the full range of medical, genetic, policy, and moral challenges. Gene discovery is being facilitated by a variety of powerful approaches, but is in its infancy. It is not surprising that the genes discovered so far act in a variety of ways: via altered metabolism of drug (the alcohol and nicotine metabolic gene variants), via altered function of a drug receptor (the nicotinic receptor, which may alter affinity for nicotine but as discussed may also alter circuitry of reward), and via general mechanisms of addiction (genes such as monoamine oxidase A and the serotonin transporter that modulate stress response, emotion, and behavioral control). Addiction medicine today benefits from genetic studies that buttress the case for a neurobiologic origin of addictive behavior, and some general information on familially transmitted propensity that can be used to guide prevention. A few well-validated, specific predictors such as OPRM1, ADH1B, ALDH2, CHRNA5, and CYP26 have been identified and can provide some specific guidance, for example, to understand alcohol-related flushing and upper GI cancer risk (ADH1B and AKLDH2), variation in nicotine metabolism (CYP26), and, potentially, naltrexone treatment response (OPRM1). However, the genetic predictors available are few in number and account for only a small portion of the genetic variance in liability, and have not been integrated into clinical nosology or care.
Heritability (weighted means and ranges) of 10 addictive disorders: hallucinogens, cannabis, stimulants, sedatives, opiates, and cocaine dependence or abuse; alcohol dependence; smoking; caffeine consumption or heavy use; pathologic gambling. Weighted heritability (h2) means were computed using data from large surveys of adult twins. (Adapted from Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet 2005;6(7):521β32.)
Impact of psychiatric disease status, smoking behavior, and Asp398Asn influence on dorsal anterior cingulateβright ventral striatum functional connectivity. (A) Asn398 carriers as compared to Asp398/Asp398 homozygotes displayed reduced connectivity. Independently from genotype effect, reduced connectivity was also found in smokers (SK) vs nonsmokers (NS) and in psychiatric patients as compared to healthy participants. (B) Nicotine craving was negatively correlated with functional connectivity of dorsal anterior cingulateβventral stria-tum in both smokers with and without psychiatric illnesses. (Adapted from Hong LE, Hodgkinson CA, Yang Y, et al. A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci U S A 2010;107(30):13509β14.)
Rare and common MAOA variants. (A) Dutch pedigree with eight males affected by Brunner syndrome, X-linked behavioral dyscontrol caused by an MAOA stop codon (C936T). (B) The MAOA-linked polymorphic region (MAOAβLPR) is a common 30-bp VNTR located approximately 1.2 kb upstream from the MAOA start codon and within the transcriptional control region. The three-repeat allele is transcribed less efficiently, leading to lower MAOA enzyme activity and behavioral consequences. ([A] Adapted from Brunner HG, Nelen M, Breakefield XO, et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993;262(5133):578β80.)
Genetic complexity in unrelated individuals: epistasis and heterogeneity. Each risk allele is represented as a puzzle piece of different color or shape. Black circles indicate affected individuals and empty circles denote unaffected individuals. (Adapted from Gold man D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet 2005;6(7):521β32.)
Genetic complexity and twin concordance: epistasis and heterogeneity. Each risk allele is represented as a puzzle piece of different color or shape. Members of twin pairs are represented by squares. Black squares indicate affected individuals and empty squares denote unaffected individuals. (Adapted from Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet 2005;6(7):521β32.)
MZ/DZ twin concordance ratios for 10 addictions. MZ/DZ ratios tend to converge on two, inconsistent with the epistatic model (see text). (Adapted from Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet 2005;6(7):521β32.)
Additive effects of the TTC12βANKK1βDRD2 and CHRNA5βCHRNA3βCHRNB4 gene clusters on smoking behavior in adolescence and adulthood. Risk of heavy smoking increases linearly with the number of risk alleles at the two loci. Odds ratios (OR) and 95% confidence intervals (CI). (Adapted from Ducci F, Kaakinen M, Pouta A, et al. TTC12βANKK1βDRD2 and CHRNA5βCHRNA3βCHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Biol Psychiatry 2011;69(7):650β60.)
Functional polymorphisms in ethanol metabolism: ADH1B His48Arg and ALDH2 Glu487Lys. Higher activity of ADH1B, conferred by Arg48, or lower activity of ALDH2, conferred by Lys487, leads to accumulation of acetaldehyde after alcohol consumption and the flushing reaction.
Geographic distributions of ALDH2 Lys487 and esophageal cancer. The Lys487 allele is highly abundant in Southeast Asia but virtually absent in Europeans, Africans, and Amerindians. Southeast Asia is also an epidemiologic hotspot for esophageal cancer, consistent with genetic epidemiologic studies that have connected risk of esophageal cancer to moderate consumption of alcohol in carriers of the Lys487 allele. Acetaldehyde is a carcinogen.58 (Adapted from Li H, Borinskaya S, Yoshimura K, et al. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann Hum Genet 2009;73(Pt 3):335β45; with permission.)
The serotonin-transporter-linked polymorphic region. The human serotonin transporter promoter has a common VNTR termed HTTLPR. The major alleles within this VNTR, namelyL (long) and S (short), differ in number of copies of a 20-bpto23-bp imperfect repeat. The L allele, which leads to increased transcription efficiency, has 16 copies of the repeat and the S allele has 14 copies. Further, a relatively common, functional A > G SNP within the L allele leads to an LG allele functionally equivalent to the S allele. (Data from Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274(5292):1527-31; and Hu XZ, Lipsky RH, Zhu G, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive compulsive disorder. Am J Hum Genet 2006;78(5):815β26.)
Association between smoking (number of cigarettes smoked per day, CPD) and genetic variation within the CHRNA5-CHRNA3-CHRNB4 gene-cluster on c15q25. (A) In the Manhattan plot, level of significance (βLog P value) of association to SNPs covering 22 autosomes is shown. SNPs reaching genome-wide significance (P<10β8) are in green. (B) The chromosome 15 region contains the CHRNA5-CHRNA3-CHRNB4 gene cluster. (C) The most significant SNP within this region is rs1051730, which correlates highly with Asp398Asn. (Data from Liu JZ, Tozzi F, Waterworth DM, et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010;42(5):436-40; Hong LE, Gu H, Yang Y, et al. Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits. Arch Gen Psychiatry 2009;66(4):431β41.)
| Name | Type |
|---|---|
| abstinence | phenotype |
| acetaldehyde | drug |
| acetic acid | drug |
| ADCYAP1R1 | gene |
| addiction | phenotype |
| ADH | gene |
| ADH1B | gene |
| ADH1B Arg48 local | variant |
| ADH1B His48Arg (rs1229984) local | variant |
| adolescents | cohort |
| adverse childhood experiences | phenotype |
| African | cohort |
| aggression | phenotype |
| alcohol | phenotype |
| alcohol abuse | phenotype |
| alcohol dependence | phenotype |
| alcohol-induced flushing | phenotype |
| alcoholism | phenotype |
| alcoholism comorbid with other SUDs local | phenotype |
| alcoholism risk | phenotype |
| Alcohol Problems | phenotype |
| Alcohol-related flushing local | phenotype |
| alcohol sensitivity | phenotype |
| Alcohol Use Disorder | phenotype |
| alcohol use disorders | phenotype |
| ALDH2 | gene |
| ALDH2 Glu487Lys (rs671) local | variant |
| ALDH2 Lys487 | variant |
| altered response to nicotine agonist local | phenotype |
| amebiasis local | phenotype |
| amygdala | anatomy |
| Amygdala reactivity | phenotype |
| ANKK1 | gene |
| anterior cingulate cortex | anatomy |
| anterior cingulate-ventral striatum circuit local | anatomy |
| antisocial personality disorder | phenotype |
| anxiety | phenotype |
| arson | phenotype |
| ASPD | phenotype |
| attempted rape | phenotype |
| attention deficit hyperactivity disorder | phenotype |
| autism | phenotype |
| AUTS2 | gene |
| behavior | phenotype |
| behavioral control | phenotype |
| borderline mental retardation local | phenotype |
| borderline personality disorder | phenotype |
| caffeine | drug |
| caffeine dependence | phenotype |
| Cannabis addiction local | phenotype |
| cannabis dependence | phenotype |
| cannabis use | phenotype |
| Catalase | gene |
| catechols local | drug |
| central nervous system | anatomy |
| Chrna3 | gene |
| CHRNA5 | gene |
| CHRNA5 Asn398 local | variant |
| CHRNA5 Asn398Asp106 local | variant |
| CHRNA5 Asp398Asn local | variant |
| CHRNA5 D398 local | variant |
| CHRNA5 N398 local | variant |
| Chrnb4 | gene |
| clinical improvement local | phenotype |
| cocaine | phenotype |
| cognition | phenotype |
| common variants | cohort |
| COMT | gene |
| COMT knockout mice local | cohort |
| COMT Met158 local | variant |
| COMT Val158 | gene |
| conduct disorder | phenotype |
| cortisol | drug |
| cotinine | drug |
| CRHR1 | gene |
| CYP26 local | gene |
| CYP2A6 | gene |
| cytochrome P450 | gene |
| DBH | gene |
| delay discounting | phenotype |
| depression | phenotype |
| disulfiram | drug |
| dopamine | drug |
| dopamine level | phenotype |
| DRD2 | gene |
| Dutch pedigree local | cohort |
| dyscontrolled behavior local | phenotype |
| early trauma | phenotype |
| East Asian | cohort |
| EEG | phenotype |
| Emotion | phenotype |
| endophenotype | phenotype |
| epistasis local | variant |
| esophageal cancer | phenotype |
| estrogen | drug |
| ethanol consumption | phenotype |
| European ancestry | cohort |
| European population | cohort |
| executive function | phenotype |
| exhibitionism | phenotype |
| externalizing disorders | phenotype |
| families | cohort |
| fighting | phenotype |
| Finnish community sample local | cohort |
| Finnish community sample (5000 Finns) local | cohort |
| Finnish late-onset alcoholics local | cohort |
| Finnish population | cohort |
| Finnish social drinkers local | cohort |
| Fkbp5 | gene |
| flushing | phenotype |
| founder populations | cohort |
| frontal cortex | anatomy |
| GABRA6 | gene |
| genetic variants | cohort |
| hallucinogens | drug |
| harm avoidance | phenotype |
| headache | phenotype |
| heavy smoking | phenotype |
| higher MAOA enzyme activity local | phenotype |
| histamine | drug |
| HTR2B | gene |
| HTR2B knockout mice local | cohort |
| HTR2B stop codon | variant |
| Htr3b | gene |
| HTTLPR local | variant |
| HTTLPR L allele local | variant |
| HTTLPR LG allele local | variant |
| HTTLPR S allele local | variant |
| human brain | anatomy |
| humans | cohort |
| hypothalamic-pituitary-adrenal axis | anatomy |
| illicit drug use | phenotype |
| impulsivity | phenotype |
| increased short-term desensitization local | phenotype |
| Inefficient frontal lobe function local | phenotype |
| initiation | phenotype |
| intermediate phenotypes | phenotype |
| internalizing disorders | phenotype |
| Jewish population local | cohort |
| Kendler twin study local | cohort |
| l allele | variant |
| lowered Ca permeability local | phenotype |
| lower MAOA enzyme activity local | phenotype |
| lung cancer | phenotype |
| MAOA | gene |
| MAOA knockout mice local | cohort |
| MAOA-LPR | variant |
| MAOA stop codon local | variant |
| MAOA stop codon (exon 8) local | variant |
| MAOA upstream VNTR local | variant |
| MAOA VNTR 3-repeat allele local | variant |
| MAOA VNTR 4-repeat allele local | variant |
| MAOA VNTR lower activity allele local | variant |
| Met158 allele local | variant |
| methamphetamine dependence | phenotype |
| metronidazole local | drug |
| mixed outbred populations local | cohort |
| monkeys | cohort |
| mood disorders | phenotype |
| Mouse model of voluntary alcohol consumption local | cohort |
| MZ/DZ concordance ratios local | phenotype |
| naltrexone | drug |
| Native American women local | cohort |
| nausea | phenotype |
| nicotine | drug |
| nicotine addiction | phenotype |
| nicotine agonist local | drug |
| nicotine dependence | phenotype |
| Nicotine metabolism variation local | phenotype |
| nicotinic acetylcholine receptor | drug |
| No pathologic drug use local | phenotype |
| norepinephrine | drug |
| novelty seeking | phenotype |
| NPY | gene |
| Nr3c1 | gene |
| number of cigarettes smoked per day | phenotype |
| occasional smokers | phenotype |
| OPRM1 | cohort |
| OPRM1 A118G | cohort |
| OPRM1 Asn398Asp local | variant |
| Oropharyngeal cancer | phenotype |
| Painβstress response local | phenotype |
| Pain threshold local | phenotype |
| Palpitations | phenotype |
| panic disorder | phenotype |
| pathological gambling | phenotype |
| personality traits | phenotype |
| phenotype | phenotype |
| pleasurable response to smoking | phenotype |
| Polysubstance addiction local | phenotype |
| population-matched controls local | cohort |
| postmortem brain | anatomy |
| prefrontal cognitive function local | phenotype |
| prefrontal cortex | anatomy |
| protozoal infections of the gut local | phenotype |
| Psychiatric_Diseases local | phenotype |
| psychiatric disorders | phenotype |
| psychopathology | phenotype |
| Q20* local | variant |
| rare variant | cohort |
| recovering alcoholics local | cohort |
| regular smoking | phenotype |
| reward | phenotype |
| reward function local | phenotype |
| reward processes local | phenotype |
| rh-5HTTLPR local | variant |
| rs10502172 | variant |
| rs16969968 | variant |
| rs25531 local | variant |
| rs6943555 | variant |
| s allele | cohort |
| schizophrenia | phenotype |
| serotonin | drug |
| serotonin-specific reuptake inhibitors local | drug |
| serum cotinine levels local | phenotype |
| severe impulsive aggression local | phenotype |
| severe impulsivity local | phenotype |
| Severe pattern of smoking local | phenotype |
| severity of smoking local | phenotype |
| sex hormones | drug |
| SLC6A4 | gene |
| smoking | phenotype |
| smoking behavior | phenotype |
| smoking cessation | phenotype |
| smoking persistence | phenotype |
| smoking quantity | phenotype |
| smoking status | phenotype |
| social phobia | phenotype |
| stress | phenotype |
| Stress resilience local | phenotype |
| stress resiliency local | phenotype |
| stress response | phenotype |
| substance use | phenotype |
| SUD | phenotype |
| suicide | phenotype |
| testosterone | drug |
| Tolcapone | drug |
| TTC12 | gene |
| Twin cohort | cohort |
| Twin_Studies local | cohort |
| upper gastrointestinal cancer | phenotype |
| Upper GI cancer risk local | phenotype |
| Val158 allele | gene |
| Val158Met | gene |
| vascular disease | phenotype |
| ventral striatum | anatomy |
| ventromedial prefrontal cortex | anatomy |
| violence | phenotype |
| violent offenders local | cohort |
| Virginia twin sample local | cohort |
| whole brain | anatomy |
| working memory | phenotype |
| working memory difference local | phenotype |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Large-scale behavioral characterization of oxycodone self-administration in heterogeneous stock rats reveals initial analgesic effects are associated with addiction-like behaviors. | Kallupi M et al. | β | 2026 | β |
| The role of cumulative adverse childhood experiences in the interrelationships among addictive behaviors: A network analysis study. | Veneziani G et al. | β | 2026 | β |
| Addiction Susceptibility: Genetic Factors, Personality Traits, and Epigenetic Interactions with the Gut Microbiome. | Borrego-Ruiz A et al. | β | 2025 | β |
| A review of brain structural and functional changes using MRI technology in patients who received bariatric surgery. | Sandoval H et al. | β | 2025 | β |
| Associations between cannabis use frequency and suicidal thoughts and behaviors: A clinical longitudinal sibling study. | Stern EF et al. | β | 2025 | β |
| A Systematic Investigation of the Common Genetic Architecture of Substance Use Traits and the Relationship with Mental Health. | Pasman JA et al. | β | 2025 | β |
| Atp1a2 and Kcnj9 Are Candidate Genes Underlying Sensitivity to Oxycodone-Induced Locomotor Activation and Withdrawal-Induced Anxiety-Like Behaviors in C57BL/6 Substrains. | Goldberg LR et al. | β | 2025 | β |
| Comprehensive examination of demographic, psychological, cognitive, biochemical, and genetic profiles of methamphetamine addicts. | Hussain HK et al. | β | 2025 | β |
| Effects of PDYN 68-bpVNTR, BDNF rs6265, OPRD1 rs569356 and OPRM1 rs2075572 polymorphisms on opioid-methamphetamine co-use. | Ak M et al. | β | 2025 | β |
| Exploring Pathways from Childhood Adversity to Substance Use in Young Adults. | Sinkevicius LV et al. | β | 2025 | β |
| Genetic and Epigenetic Approaches to Opioid Use Disorder. | Ranadeva ND et al. | β | 2025 | β |
| Genetic mapping in collaborative cross mouse strains identifies loci that affect initial sensitivity to cocaine. | Schoenrock SA et al. | β | 2025 | β |
| Identifying predictors of multi-year cannabis vaping in U.S. Young adults using machine learning. | Choe S et al. | β | 2025 | β |
| Non-Suicidal Self-Injury and Exercise: Associations With Addiction. | Lee HS et al. | β | 2025 | β |
| Polygenic Risk for Substance Use Disorders as Predictors of Substance Use Initiation Among African American Youth. | Sosnowski DW et al. | β | 2025 | β |
| Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk. | Green RP et al. | β | 2025 | β |
| Risk Factors and Onset of Illicit Drug Use among Filipino Youth: A Cross-sectional Analysis of Sociodemographic and Environmental Influences. | Baula EU et al. | β | 2025 | β |
| Validation studies and multiomics analysis of Zhx2 as a candidate quantitative trait gene underlying brain oxycodone metabolite (oxymorphone) levels and behavior. | Lynch WB et al. | β | 2025 | β |
| Associations between methamphetamine use disorder and <i>SLC18A1</i>, <i>SLC18A2</i>, <i>BDNF</i>, and <i>FAAH</i> gene sequence variants and expression levels. | Guerin AA et al. | β | 2024 | β |
| Discovery and validation of genes driving drug-intake and related behavioral traits in mice. | Roy TA et al. | β | 2024 | β |
| Dopamine Pharmacodynamics: New Insights. | Lauretani F et al. | β | 2024 | β |
| Effect of MAOA rs1465108 polymorphism on susceptibility to substance/alcohol use disorder: a novel PCR-RFLP assay for the detection of MAOA rs1465108. | Kaya-AkyΓΌzlΓΌ D et al. | β | 2024 | β |
| Environmental enrichment promotes adaptive responding during tests of behavioral regulation in male heterogeneous stock rats. | Ishiwari K et al. | β | 2024 | β |
| Epigenetic inheritance of phenotypes associated with parental exposure to cocaine. | Rich MT et al. | β | 2024 | β |
| Exploring perceptions of genetic risk and the transmission of substance use disorders. | Keller A et al. | β | 2024 | β |
| Genetics of gambling disorder and related phenotypes: The potential uses of polygenic and multifactorial risk models to enable early detection and improve clinical outcomes. | Warrier V et al. | β | 2024 | β |
| Genetic susceptibility to caffeine intake and metabolism: a systematic review. | Low JJ et al. | β | 2024 | β |
| Stress and substance use disorders: risk, relapse, and treatment outcomes. | Sinha R | β | 2024 | β |
| The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. | β | β | 2024 | β |
| The influence of adverse childhood experiences and depression on addiction severity among methamphetamine users: exploring the role of perseveration. | Ko CH et al. | β | 2024 | β |
| Analysis of the Methylation Level of the <i>DAT1</i> Dopamine Transporter Gene in Patients Addicted to Stimulants, Taking into Account an Analysis of Personality Traits. | RecΕaw R et al. | β | 2023 | β |
| A novel tetra-primer ARMS-PCR for genotyping of the OPRM1 gene rs1799971 variant associated with opioid use disorders. | Wijekumar PJ et al. | β | 2023 | β |
| Climate Change and Substance-Use Behaviors: A Risk-Pathways Framework. | Vergunst F et al. | β | 2023 | β |
| DISCOVERY AND VALIDATION OF GENES DRIVING DRUG-INTAKE AND RELATED BEHAVIORAL TRAITS IN MICE | Roy TA et al. | β | 2023 | β |
| Intravenous fentanyl self-administration in male and female C57BL/6J and DBA/2J mice. | Leonardo M et al. | β | 2023 | β |
| Low Dopamine D2 Receptor Expression Drives Gene Networks Related to GABA, cAMP, Growth and Neuroinflammation in Striatal Indirect Pathway Neurons. | Guerri L et al. | β | 2023 | β |
| Multi-animal-model study reveals mutations in neural plasticity and nociception genes linked to excessive alcohol drinking. | Muir WM et al. | β | 2023 | β |
| Neurogenetics and Epigenetics of Loneliness. | Bowirrat A et al. | β | 2023 | β |
| Risk Factors for Substance Use across the Lifespan. | Stewart SA et al. | β | 2023 | β |
| Urban neighbourhood elements that influence psychoactive substance use among populations with adverse childhood experiences: a scoping review protocol. | Baishya M et al. | β | 2023 | β |
| Adolescent cocaine differentially impacts psychomotor sensitization and epigenetic profiles in adult male rats with divergent affective phenotypes. | Parsegian A et al. | β | 2022 | β |
| Application of optogenetics and in vivo imaging approaches for elucidating the neurobiology of addiction. | Vickstrom CR et al. | β | 2022 | β |
| Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the <i>DRD2</i> Gene with Neuroticism in Patients with Substance Use Disorder. | BoroΕ A et al. | β | 2022 | β |
| Clinical and basic research investigations into the long-term effects of prenatal opioid exposure on brain development. | Boggess T et al. | β | 2022 | β |
| Cocaine-Induced Locomotor Activation Differs Across Inbred Mouse Substrains. | Gaines CH et al. | β | 2022 | β |
| Contributions of epigenetic inheritance to the predisposition of major psychiatric disorders: Theoretical framework, evidence, and implications. | Varela RB et al. | β | 2022 | β |
| Differentially Expressed Genes in <i>Period 2</i>-Overexpressing Mice Striatum May Underlie Their Lower Sensitivity to Methamphetamine Addiction-Like Behavior. | Sayson LV et al. | β | 2022 | β |
| Differential transcriptome profile underlying risky choice in a rat gambling task. | Kwak MJ et al. | β | 2022 | β |
| Genetic influences impacting nicotine use and abuse during adolescence: Insights from human and rodent studies. | Goldberg LR et al. | β | 2022 | β |
| Paternal alcohol exposure has task- and sex-dependent behavioral effect in offspring. | Nieto SJ et al. | β | 2022 | β |
| Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review. | White O et al. | β | 2022 | β |
| Strong and weak cross-inheritance of substance use disorders in a nationally representative sample. | Zhang H et al. | β | 2022 | β |
| Substance Use among Youth in Community and Residential Mental Health Care Facilities in Ontario, Canada. | Aderibigbe OO et al. | β | 2022 | β |
| The collaborative cross strains and their founders vary widely in cocaine-induced behavioral sensitization. | Schoenrock SA et al. | β | 2022 | β |
| The Use of <i>Drosophila</i> to Understand Psychostimulant Responses. | Philyaw TJ et al. | β | 2022 | β |
| Trajectories of adolescent poly-substance use and their long-term social and economic outcomes for males from low-income backgrounds. | Vergunst F et al. | β | 2022 | β |
| A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity. | Goldberg LR et al. | β | 2021 | β |
| Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users. | Yuferov V et al. | β | 2021 | β |
| BXD Recombinant Inbred Mice as a Model to Study Neurotoxicity. | Martins AC et al. | β | 2021 | β |
| Candidate pharmacological treatments for substance use disorder and suicide identified by gene co-expression network-based drug repositioning. | Cabrera-Mendoza B et al. | β | 2021 | β |
| Catechol-O-methyltransferase and dopamine receptor D4 gene variants: Possible association with substance abuse in Bangladeshi male. | Sonia JA et al. | β | 2021 | β |
| Child reward neurocircuitry and parental substance use history: Findings from the Adolescent Brain Cognitive Development Study. | Kwarteng AE et al. | β | 2021 | β |
| Different biases in meta-analyses of case-control and cohort studies: an example from genomics and precision medicine. | Palumbo SA et al. | β | 2021 | β |
| Exploring the genetic overlap of suicide-related behaviors and substance use disorders. | Colbert SMC et al. | β | 2021 | β |
| Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder. | Castaldelli-Maia JM et al. | β | 2021 | β |
| Exposure to drugs of abuse induce effects that persist across generations. | Baratta AM et al. | β | 2021 | β |
| Factors modulating the incubation of drug and non-drug craving and their clinical implications. | Venniro M et al. | β | 2021 | β |
| Generational Effects of Opioid Exposure. | Odegaard KE et al. | β | 2021 | β |
| Genetic basis of cannabis use: a systematic review. | Hillmer A et al. | β | 2021 | β |
| Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies. | Guerin AA et al. | β | 2021 | β |
| Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study. | PΓ©rez-Rubio G et al. | β | 2021 | β |
| HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study). | BarrΓ© T et al. | β | 2021 | β |
| Molecular genetics of substance use disorders: An umbrella review. | Lopez-Leon S et al. | β | 2021 | β |
| Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis. | Navarro-Zaragoza J et al. | β | 2021 | β |
| Pharmacokinetic and pharmacodynamic analyses of cocaine and its metabolites in behaviorally divergent inbred mouse strains. | Zhu J et al. | β | 2021 | β |
| Spontaneously Hypertensive Rat substrains show differences in model traits for addiction risk and cocaine self-administration: Implications for a novel rat reduced complexity cross. | Kantak KM et al. | β | 2021 | β |
| The Cocaine and Oxycodone Biobanks, Two Repositories from Genetically Diverse and Behaviorally Characterized Rats for the Study of Addiction. | Carrette LLG et al. | β | 2021 | β |
| Understanding the genetics and neurobiological pathways behind addiction (Review). | Popescu A et al. | β | 2021 | β |
| Voluntary intake of psychoactive substances is regulated by the dopamine receptor Dop1R1 in Drosophila. | Kanno M et al. | β | 2021 | β |
| Adverse childhood experiences in families with multiple members diagnosed to have psychiatric illnesses. | Someshwar A et al. | β | 2020 | β |
| Associations Among Internet Addiction, Genetic Polymorphisms, Family Functioning, and Psychopathological Risk: Cross-Sectional Exploratory Study. | Cerniglia L et al. | β | 2020 | β |
| Discovery of a Role for <i>Rab3b</i> in Habituation and Cocaine Induced Locomotor Activation in Mice Using Heterogeneous Functional Genomic Analysis. | Bubier JA et al. | β | 2020 | β |
| Genesis of the Heroin-Induced Addictive Process: Articulation Between Psychodynamic and Neurobiological Theories. | Scarna H | β | 2020 | β |
| Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution. | Icick R et al. | β | 2020 | β |
| Non-genetic factors that influence methamphetamine intake in a genetic model of differential methamphetamine consumption. | Stafford AM et al. | β | 2020 | β |
| Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas. | Eckardt P et al. | β | 2020 | β |
| Substance use: Interplay between polygenic risk and neighborhood environment. | Pasman JA et al. | β | 2020 | β |
| The Science of Addiction Through the Lens of Opioid Treatment for Chronic Noncancer Pain. | Umberger W et al. | β | 2020 | β |
| Who is HOT and who is LOT? Detailed characterization of prescription opioid-induced changes in behavior between 129P3/J and 129S1/SvlmJ mouse substrains. | Szumlinski KK et al. | β | 2020 | β |
| A developmental model of addictions: integrating neurobiological and psychodynamic theories through the lens of attachment. | Alvarez-Monjaras M et al. | β | 2019 | β |
| Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry. | Brick LA et al. | β | 2019 | β |
| Decreased brain connectivity in smoking contrasts with increased connectivity in drinking. | Cheng W et al. | β | 2019 | β |
| Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia. | Kaski SW et al. | β | 2019 | β |
| Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions. | Cabana-DomΓnguez J et al. | β | 2019 | β |
| Interactions between monoamine oxidase A rs1137070 and smoking on brain structure and function in male smokers. | Shen Z et al. | β | 2019 | β |
| Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function. | Goldberg LR et al. | β | 2019 | β |
| Prosocial Emotion, Adolescence, and Warfare : DNA Methylation Associates with Culturally Salient Combat Variables. | Straight B et al. | β | 2019 | β |
| Reward Processing in Drug-Naive Youth with Various Levels of Risk for Substance Use Disorders: A Pilot Study. | Ivanov I et al. | β | 2019 | β |
| Sex-Dimorphic Interactions of <i>MAOA</i> Genotype and Child Maltreatment Predispose College Students to Polysubstance Use. | Fite PJ et al. | β | 2019 | β |
| Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry. | Popova D et al. | β | 2019 | β |
| Systematic Review of Polygenic Gene-Environment Interaction in Tobacco, Alcohol, and Cannabis Use. | Pasman JA et al. | β | 2019 | β |
| Systems genetics of sensation seeking. | Dickson PE et al. | β | 2019 | β |
| Who's your daddy? Behavioral and epigenetic consequences of paternal drug exposure. | Nieto SJ et al. | β | 2019 | β |
| Association between serotonin 2A receptor genetic variations, stressful life events and suicide. | Ghasemi A et al. | β | 2018 | β |
| Distinct Roles for Two Chromosome 1 Loci in Ethanol Withdrawal, Consumption, and Conditioned Place Preference. | Kozell LB et al. | β | 2018 | β |
| Drug addiction: a curable mental disorder? | Liu JF et al. | β | 2018 | β |
| Focusing on the Opioid System for Addiction Biomarker Discovery. | Belzeaux R et al. | β | 2018 | β |
| Investigating the genetic profile of dopaminergic neurons in the VTA in response to perinatal nicotine exposure using mRNA-miRNA analyses. | Keller RF et al. | β | 2018 | β |
| Neuroepigenetics of Neurotrophin Signaling: Neurobiology of Anxiety and Affective Disorders. | RΓ¨gue-Guyon M et al. | β | 2018 | β |
| Novel human genome variants associated with alcohol use disorders identified in a Lithuanian cohort. | Baronas K et al. | β | 2018 | β |
| The Benefits of Genetic Addiction Risk Score (GARS<sup>β’</sup>) Testing in Substance Use Disorder (SUD). | Blum K et al. | β | 2018 | β |
| The genetic and environmental architecture of substance use development from early adolescence into young adulthood: a longitudinal twin study of comorbidity of alcohol, tobacco and illicit drug use. | Waaktaar T et al. | β | 2018 | β |
| Altered reward sensitivity in female offspring of cocaine-exposed fathers. | Fischer DK et al. | β | 2017 | β |
| An Update on the Role of Serotonin and its Interplay with Dopamine for Reward. | Fischer AG et al. | β | 2017 | β |
| Applications of CRISPR/Cas9 in the Mammalian Central Nervous System. | Savell KE et al. | β | 2017 | β |
| Behavioral Genetics in Criminal and Civil Courts. | Sabatello M et al. | β | 2017 | β |
| Effects of crack cocaine addiction and stress-related genes on peripheral BDNF levels. | Rovaris DL et al. | β | 2017 | β |
| Gene expression profiling in the human alcoholic brain. | Warden AS et al. | β | 2017 | β |
| Genetics of addictive behavior: the example of nicotine dependence. | Gorwood P et al. | β | 2017 | β |
| GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM<sup>β’</sup>): LESSONS LEARNED FROM AMERICA. | Blum K et al. | β | 2017 | β |
| Heritability of lifetime ecstasy use. | Verweij KJH et al. | β | 2017 | β |
| The biology of addiction. | MacNicol B | β | 2017 | β |
| Two novel candidate genes identified in adults from the Newfoundland population with addictive tendencies towards food. | Pedram P et al. | β | 2017 | β |
| Variability in prescription opioid intake and reinforcement amongst 129 substrains. | Jimenez SM et al. | β | 2017 | β |
| A Systems Approach Implicates a Brain Mitochondrial Oxidative Homeostasis Co-expression Network in Genetic Vulnerability to Alcohol Withdrawal. | Walter NA et al. | β | 2016 | β |
| Candidate genes for alcohol dependence: A genetic association study from India. | Malhotra S et al. | β | 2016 | β |
| Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions. | Yang J et al. | β | 2016 | β |
| Smokescreen: a targeted genotyping array for addiction research. | Baurley JW et al. | β | 2016 | β |
| THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS. | Blum K et al. | β | 2016 | β |
| Utility of Machine-Learning Approaches to Identify Behavioral Markers for Substance Use Disorders: Impulsivity Dimensions as Predictors of Current Cocaine Dependence. | Ahn WY et al. | β | 2016 | β |
| Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy. | Thompson MD et al. | β | 2016 | β |
| Association of substance dependence phenotypes in the COGA sample. | Wetherill L et al. | β | 2015 | β |
| Biomarkers in substance use disorders. | Volkow ND et al. | β | 2015 | β |
| Differences in subjective response to alcohol in heavy- and light-drinking Chinese men versus Caucasian American men. | Rueger SY et al. | β | 2015 | β |
| DRD4 and SLC6A3 gene polymorphisms are associated with food intake and nutritional status in children in early stages of development. | Fontana C et al. | β | 2015 | β |
| Endocannabinoid signalling in reward and addiction. | Parsons LH et al. | β | 2015 | β |
| Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility. | Blum K et al. | β | 2015 | β |
| Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction. | Blum K et al. | β | 2015 | β |
| Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? | Blum K et al. | β | 2015 | β |
| New Drugs of Abuse and Withdrawal Syndromes. | Andrabi S et al. | β | 2015 | β |
| Novel MPDZ/MUPP1 transgenic and knockdown models confirm Mpdz's role in ethanol withdrawal and support its role in voluntary ethanol consumption. | Milner LC et al. | β | 2015 | β |
| Resting-state functional connectivity and nicotine addiction: prospects for biomarker development. | Fedota JR et al. | β | 2015 | β |
| Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. | Howell LL et al. | β | 2015 | β |
| Behavioral architecture of opioid reward and aversion in C57BL/6 substrains. | Kirkpatrick SL et al. | β | 2014 | β |
| Initial subjective reward: single-exposure conditioned place preference to alcohol in mice. | Grisel JE et al. | β | 2014 | β |
| Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning. | Janero DR | β | 2014 | β |
| Reducing substance use during adolescence: a translational framework for prevention. | Stanis JJ et al. | β | 2014 | β |
| Risk-assessment and risk-taking behavior predict potassium- and amphetamine-induced dopamine response in the dorsal striatum of rats. | Palm S et al. | β | 2014 | β |
| Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. | Cunningham KA et al. | β | 2014 | β |
| Subgroup-dependent effects of voluntary alcohol intake on behavioral profiles in outbred Wistar rats. | Momeni S et al. | β | 2014 | β |
| Constitutive knockout of kalirin-7 leads to increased rates of cocaine self-administration. | Kiraly DD et al. | β | 2013 | β |
| Forgiving the sins of the fathers. | Scofield MD et al. | β | 2013 | β |
| Genetic markers of a Munc13 protein family member, BAIAP3, are gender specifically associated with anxiety and benzodiazepine abuse in mice and humans. | Wojcik SM et al. | β | 2013 | β |
| Molecular and genetic determinants of alcohol dependence. | Awofala AA | β | 2013 | β |
| OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. | Haerian BS et al. | β | 2013 | β |
| Relevance of hypersexual disorder to family medicine and primary care as a complex multidimensional chronic disease construct. | Borgermans L et al. | β | 2013 | β |
| The ΞΌ-opioid receptor and treatment response to naltrexone. | Thorsell A | β | 2013 | β |
| What do Differences in Emotional Regulation in Individuals Addicted to Different Substances Tell us About Addiction Treatment? | Scott Hall F | β | 2013 | β |